{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:08:30Z","timestamp":1775041710175,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00217705"],"award-info":[{"award-number":["RS-2023-00217705"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2022R1A2C1091488"],"award-info":[{"award-number":["2022R1A2C1091488"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"DOI":"10.1186\/s12859-026-06371-w","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:48:31Z","timestamp":1772113711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BDDN: bayesian dynamic differential network analysis in cancer proteomics"],"prefix":"10.1186","volume":"27","author":[{"given":"Juan","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jina","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ick Hoon","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Jin","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"6371_CR1","doi-asserted-by":"publisher","DOI":"10.1385\/1592591302","volume-title":"Introduction to proteomics: tools for the new biology","author":"DC Liebler","year":"2001","unstructured":"Liebler DC. Introduction to proteomics: tools for the new biology. Totowa, New Jersey: Springer; 2001."},{"key":"6371_CR2","first-page":"166","volume-title":"Proteins","author":"B Alberts","year":"2014","unstructured":"Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Proteins. 6th ed. New York: Garland Science; 2014. p. 166\u201372.","edition":"6"},{"issue":"1","key":"6371_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42485-022-00100-6","volume":"14","author":"S Dutta","year":"2023","unstructured":"Dutta S, Ghosh S, Mishra A, Ghosh R. Oncoproteomics: insight into current proteomic technologies in cancer biomarker discovery and treatment. J Proteins Proteomics. 2023;14(1):1\u201324. https:\/\/doi.org\/10.1007\/s42485-022-00100-6.","journal-title":"J Proteins Proteomics"},{"issue":"7620","key":"6371_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold R, Mann M. Mass-spectrometric exploration of proteome structure and function. Nature. 2016;537(7620):347\u201355. https:\/\/doi.org\/10.1038\/nature19949.","journal-title":"Nature"},{"issue":"1","key":"6371_CR5","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1038\/s41467-023-39241-7","volume":"14","author":"A Rodina","year":"2023","unstructured":"Rodina A, Xu C, Digwal CS, Joshi S, Patel Y, Santhaseela AR, et al. Systems-level analyses of protein-protein interaction network dysfunctions via epichaperomics identify cancer-specific mechanisms of stress adaptation. Nat Commun. 2023;14(1):3742. https:\/\/doi.org\/10.1038\/s41467-023-39241-7.","journal-title":"Nat Commun"},{"issue":"4","key":"6371_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/ajco.14095","volume":"20","author":"F Sajjad","year":"2024","unstructured":"Sajjad F, Jalal A, Jalal A, Mubeen H, Rizvi SZ, Nisa A, et al. Multi-omic analysis of dysregulated pathways in triple negative breast cancer. Asia Pac J Clin Oncol. 2024;20(4):450\u201362. https:\/\/doi.org\/10.1111\/ajco.14095.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"18","key":"6371_CR7","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1016\/j.cell.2023.07.013","volume":"186","author":"Y Geffen","year":"2023","unstructured":"Geffen Y, Anand S, Akiyama Y, Yaron TM, Song Y, Johnson JL, et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell. 2023;186(18):3945\u201367. https:\/\/doi.org\/10.1016\/j.cell.2023.07.013.","journal-title":"Cell"},{"key":"6371_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-020-01197-3","volume":"19","author":"Y Lu","year":"2020","unstructured":"Lu Y, Chan Y-T, Tan H-Y, Li S, Wang N, Feng Y. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy. Mol Cancer. 2020;19:1\u201316. https:\/\/doi.org\/10.1186\/s12943-020-01197-3.","journal-title":"Mol Cancer"},{"issue":"1","key":"6371_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41597-021-00890-2","volume":"8","author":"AF Jarnuczak","year":"2021","unstructured":"Jarnuczak AF, Najgebauer H, Barzine M, Kundu DJ, Ghavidel F, Perez-Riverol Y, et al. An integrated landscape of protein expression in human cancer. Scientific data. 2021;8(1):115. https:\/\/doi.org\/10.1038\/s41597-021-00890-2.","journal-title":"Scientific data"},{"issue":"1","key":"6371_CR10","doi-asserted-by":"publisher","first-page":"41676","DOI":"10.1038\/srep41676","volume":"7","author":"A Rai","year":"2017","unstructured":"Rai A, Pradhan P, Nagraj J, Lohitesh K, Chowdhury R, Jalan S. Understanding cancer complexome using networks, spectral graph theory and multilayer framework. Sci Rep. 2017;7(1):41676. https:\/\/doi.org\/10.1038\/srep41676.","journal-title":"Sci Rep"},{"issue":"6563","key":"6371_CR11","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1126\/science.abf3066","volume":"374","author":"M Kim","year":"2021","unstructured":"Kim M, Park J, Bouhaddou M, Kim K, Rojc A, Modak M, et al. A protein interaction landscape of breast cancer. Science. 2021;374(6563):3066. https:\/\/doi.org\/10.1126\/science.abf3066.","journal-title":"Science"},{"issue":"11","key":"6371_CR12","doi-asserted-by":"publisher","first-page":"48722","DOI":"10.1371\/journal.pone.0048722","volume":"7","author":"S Farkash-Amar","year":"2012","unstructured":"Farkash-Amar S, Eden E, Cohen A, Geva-Zatorsky N, Cohen L, Milo R, et al. Dynamic proteomics of human protein level and localization across the cell cycle. PLoS ONE. 2012;7(11):48722. https:\/\/doi.org\/10.1371\/journal.pone.0048722.","journal-title":"PLoS ONE"},{"key":"6371_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2043-9113-3-19","volume":"3","author":"MF Islam","year":"2013","unstructured":"Islam MF, Hoque MM, Banik RS, Roy S, Sumi SS, Hassan FN, et al. Comparative analysis of differential network modularity in tissue specific normal and cancer protein interaction networks. J Clin Bioinform. 2013;3:1\u201323. https:\/\/doi.org\/10.1186\/2043-9113-3-19.","journal-title":"J Clin Bioinform"},{"key":"6371_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ymeth.2016.08.015","volume":"111","author":"Y Zuo","year":"2016","unstructured":"Zuo Y, Cui Y, Di Poto C, Varghese RS, Yu G, Li R, et al. Indeed: integrated differential expression and differential network analysis of omic data for biomarker discovery. Methods. 2016;111:12\u201320. https:\/\/doi.org\/10.1016\/j.ymeth.2016.08.015.","journal-title":"Methods"},{"issue":"23","key":"6371_CR15","doi-asserted-by":"publisher","first-page":"6774","DOI":"10.1158\/0008-5472.CAN-16-2961","volume":"76","author":"TC Archer","year":"2016","unstructured":"Archer TC, Fertig EJ, Gosline SJC, Hafner M, Hughes SK, Joughin BA, et al. Systems approaches to cancer biology. Can Res. 2016;76(23):6774\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2961.","journal-title":"Can Res"},{"issue":"1","key":"6371_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/msb.2011.99","volume":"8","author":"T Ideker","year":"2012","unstructured":"Ideker T, Krogan NJ. Differential network biology. Mol Syst Biol. 2012;8(1):565. https:\/\/doi.org\/10.1038\/msb.2011.99.","journal-title":"Mol Syst Biol"},{"issue":"23","key":"6371_CR17","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/bioinformatics\/btab502","volume":"37","author":"J-J Tu","year":"2021","unstructured":"Tu J-J, Ou-Yang L, Zhu Y, Yan H, Qin H, Zhang X-F. Differential network analysis by simultaneously considering changes in gene interactions and gene expression. Bioinformatics. 2021;37(23):4414\u201323. https:\/\/doi.org\/10.1093\/bioinformatics\/btab502.","journal-title":"Bioinformatics"},{"issue":"1","key":"6371_CR18","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12859-024-05969-2","volume":"25","author":"PH Guzzi","year":"2024","unstructured":"Guzzi PH, Roy A, Milano M, Veltri P. Non parametric differential network analysis: a tool for unveiling specific molecular signatures. BMC Bioinform. 2024;25(1):359. https:\/\/doi.org\/10.1186\/s12859-024-05969-2.","journal-title":"BMC Bioinform"},{"issue":"1","key":"6371_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13045-023-01517-2","volume":"16","author":"W-M Song","year":"2023","unstructured":"Song W-M, Elmas A, Farias R, Xu P, Zhou X, Hopkins B, et al. Multiscale protein networks systematically identify aberrant protein interactions and oncogenic regulators in seven cancer types. J Hematol Oncol. 2023;16(1):120. https:\/\/doi.org\/10.1186\/s13045-023-01517-2.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"6371_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100744","volume":"23","author":"P Lapcik","year":"2024","unstructured":"Lapcik P, Stacey RG, Potesil D, Kulhanek P, Foster LJ, Bouchal P. Global interactome mapping reveals pro-tumorigenic interactions of nf-$$\\kappa $$b in breast cancer. Molecul Cell Proteomics. 2024;23(4):100744. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100744.","journal-title":"Molecul Cell Proteomics"},{"key":"6371_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-497","volume":"11","author":"BM Tesson","year":"2010","unstructured":"Tesson BM, Breitling R, Jansen RC. Diffcoex: a simple and sensitive method to find differentially coexpressed gene modules. BMC Bioinform. 2010;11:1\u20139. https:\/\/doi.org\/10.1186\/1471-2105-11-497.","journal-title":"BMC Bioinform"},{"issue":"3","key":"6371_CR22","doi-asserted-by":"publisher","first-page":"1002955","DOI":"10.1371\/journal.pcbi.1002955","volume":"9","author":"D Amar","year":"2013","unstructured":"Amar D, Safer H, Shamir R. Dissection of regulatory networks that are altered in disease via differential co-expression. PLoS Comput Biol. 2013;9(3):1002955. https:\/\/doi.org\/10.1371\/journal.pcbi.1002955.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"6371_CR23","doi-asserted-by":"publisher","first-page":"10863","DOI":"10.1038\/s41598-019-47362-7","volume":"9","author":"H He","year":"2019","unstructured":"He H, Cao S, Zhang J-G, Shen H, Wang Y-P, Deng H-W. A statistical test for differential network analysis based on inference of gaussian graphical model. Sci Rep. 2019;9(1):10863. https:\/\/doi.org\/10.1038\/s41598-019-47362-7.","journal-title":"Sci Rep"},{"issue":"3","key":"6371_CR24","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/bioinformatics\/btab751","volume":"38","author":"J Leng","year":"2022","unstructured":"Leng J, Wu L-Y. Importance-penalized joint graphical lasso (ipjgl): differential network inference via ggms. Bioinformatics. 2022;38(3):770\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btab751.","journal-title":"Bioinformatics"},{"key":"6371_CR25","doi-asserted-by":"publisher","first-page":"1026487","DOI":"10.3389\/fgene.2022.1026487","volume":"13","author":"S Xue","year":"2022","unstructured":"Xue S, Rogers LR, Zheng M, He J, Piermarocchi C, Mias GI. Applying differential network analysis to longitudinal gene expression in response to perturbations. Front Genet. 2022;13:1026487. https:\/\/doi.org\/10.3389\/fgene.2022.1026487.","journal-title":"Front Genet"},{"issue":"4","key":"6371_CR26","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1109\/TCBB.2019.2949039","volume":"18","author":"T Xu","year":"2019","unstructured":"Xu T, Ou-Yang L, Yan H, Zhang X-F. Time-varying differential network analysis for revealing network rewiring over cancer progression. IEEE\/ACM Trans Comput Biol Bioinf. 2019;18(4):1632\u201342. https:\/\/doi.org\/10.1109\/TCBB.2019.2949039.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinf"},{"issue":"6","key":"6371_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ccell.2020.10.008","volume":"38","author":"W Zhao","year":"2020","unstructured":"Zhao W, Li J, Chen M-JM, Luo Y, Ju Z, Nesser NK, et al. Large-scale characterization of drug responses of clinically relevant proteins in cancer cell lines. Cancer Cell. 2020;38(6):829\u201343. https:\/\/doi.org\/10.1016\/j.ccell.2020.10.008.","journal-title":"Cancer Cell"},{"issue":"1","key":"6371_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7171\/jbt.21-3202-001","volume":"32","author":"C Coarfa","year":"2021","unstructured":"Coarfa C, Grimm SL, Rajapakshe K, Perera D, Lu H-Y, Wang X, et al. Reverse-phase protein array: technology, application, data processing, and integration. J Biomol Tech JBT. 2021;32(1):15. https:\/\/doi.org\/10.7171\/jbt.21-3202-001.","journal-title":"J Biomol Tech JBT"},{"issue":"7","key":"6371_CR29","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1358\/dot.2006.42.7.985637","volume":"42","author":"S Johnston","year":"2006","unstructured":"Johnston S, Leary A. Lapatinib: a novel egfr\/her2 tyrosine kinase inhibitor for cancer. Drugs Today (Barc). 2006;42(7):441\u201353. https:\/\/doi.org\/10.1358\/dot.2006.42.7.985637.","journal-title":"Drugs Today (Barc)"},{"key":"6371_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10549-010-1281-5","volume":"130","author":"G Valabrega","year":"2011","unstructured":"Valabrega G, Capellero S, Cavalloni G, Zaccarello G, Petrelli A, Migliardi G, et al. Her2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon her2 and are sensitive to the multitargeted kinase inhibitor sorafenib. Breast Cancer Res Treat. 2011;130:29\u201340. https:\/\/doi.org\/10.1007\/s10549-010-1281-5.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"6371_CR31","first-page":"2531","volume":"5","author":"M Segovia-Mendoza","year":"2015","unstructured":"Segovia-Mendoza M, Gonz\u00e1lez-Gonz\u00e1lez ME, Barrera D, D\u00edaz L, Garc\u00eda-Becerra R. Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of her2-positive breast cancer: preclinical and clinical evidence. Am J Cancer Res. 2015;5(9):2531.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"6371_CR32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.5705\/ss.2010.051","volume":"22","author":"PD Hoff","year":"2012","unstructured":"Hoff PD, Niu X. A covariance regression model. Stat Sin. 2012;22(2):729\u201353. https:\/\/doi.org\/10.5705\/ss.2010.051.","journal-title":"Stat Sin"},{"issue":"2","key":"6371_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/0025570X.1981.11976898","volume":"54","author":"KS Miller","year":"1981","unstructured":"Miller KS. On the inverse of the sum of matrices. Math Mag. 1981;54(2):67\u201372. https:\/\/doi.org\/10.1080\/0025570X.1981.11976898.","journal-title":"Math Mag"},{"key":"6371_CR34","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11634-013-0158-y","volume":"8","author":"J Jacques","year":"2014","unstructured":"Jacques J, Preda C. Functional data clustering: a survey. Adv Data Anal Classif. 2014;8:231\u201355. https:\/\/doi.org\/10.1007\/s11634-013-0158-y.","journal-title":"Adv Data Anal Classif"},{"key":"6371_CR35","doi-asserted-by":"publisher","unstructured":"Piegl L, Tiller W. B-Spline Basis Functions, pp. 47\u201379. Springer, Berlin, Heidelberg 1997. https:\/\/doi.org\/10.1007\/978-3-642-59223-2_2.","DOI":"10.1007\/978-3-642-59223-2_2"},{"issue":"6","key":"6371_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molonc.2010.09.003","volume":"4","author":"C Mueller","year":"2010","unstructured":"Mueller C, Liotta LA, Espina V. Reverse phase protein microarrays advance to use in clinical trials. Mol Oncol. 2010;4(6):461\u201381. https:\/\/doi.org\/10.1016\/j.molonc.2010.09.003.","journal-title":"Mol Oncol"},{"issue":"15","key":"6371_CR37","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1002\/pros.22518","volume":"72","author":"UT Sankpal","year":"2012","unstructured":"Sankpal UT, Abdelrahim M, Connelly SF, Lee CM, Madero-Visbal R, Colon J, et al. Small molecule tolfenamic acid inhibits pc-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer. Prostate. 2012;72(15):1648\u201358. https:\/\/doi.org\/10.1002\/pros.22518.","journal-title":"Prostate"},{"issue":"2","key":"6371_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ygyno.2010.06.030","volume":"119","author":"SC Modesitt","year":"2010","unstructured":"Modesitt SC, Parsons SJ. In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: does timing matter? Gynecol Oncol. 2010;119(2):351\u20137. https:\/\/doi.org\/10.1016\/j.ygyno.2010.06.030.","journal-title":"Gynecol Oncol"},{"issue":"16","key":"6371_CR39","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.4161\/cc.25728","volume":"12","author":"L Tang","year":"2013","unstructured":"Tang L, Wang Y, Strom A, Gustafsson J\u00c5, Guan X. Lapatinib induces p27kip1-dependent $$\\text{ g}_1$$ arrest through both transcriptional and post-translational mechanisms. Cell Cycle. 2013;12(16):2665\u201374. https:\/\/doi.org\/10.4161\/cc.25728.","journal-title":"Cell Cycle"},{"issue":"8","key":"6371_CR40","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.18632\/oncotarget.3296","volume":"6","author":"W-Y Leung","year":"2015","unstructured":"Leung W-Y, Roxanis I, Sheldon H, Buffa FM, Li J-L, Harris AL, et al. Combining lapatinib and pertuzumab to overcome lapatinib resistance due to nrg1-mediated signalling in her2-amplified breast cancer. Oncotarget. 2015;6(8):5678. https:\/\/doi.org\/10.18632\/oncotarget.3296.","journal-title":"Oncotarget"},{"issue":"11","key":"6371_CR41","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/jjco\/hyq084","volume":"40","author":"C Vogel","year":"2010","unstructured":"Vogel C, Chan A, Gril B, Kim S-B, Kurebayashi J, Liu L, et al. Management of erbb2-positive breast cancer: insights from preclinical and clinical studies with lapatinib. Jpn J Clin Oncol. 2010;40(11):999\u20131013. https:\/\/doi.org\/10.1093\/jjco\/hyq084.","journal-title":"Jpn J Clin Oncol"},{"issue":"7","key":"6371_CR42","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/genes15070903","volume":"15","author":"X Cheng","year":"2024","unstructured":"Cheng X. A comprehensive review of her2 in cancer biology and therapeutics. Genes. 2024;15(7):903. https:\/\/doi.org\/10.3390\/genes15070903.","journal-title":"Genes"},{"issue":"7","key":"6371_CR43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.18632\/oncotarget.188","volume":"1","author":"B Markman","year":"2010","unstructured":"Markman B, Dienstmann R, Tabernero J. Targeting the pi3k\/akt\/mtor pathway-beyond rapalogs. Oncotarget. 2010;1(7):530. https:\/\/doi.org\/10.18632\/oncotarget.188.","journal-title":"Oncotarget"},{"issue":"22","key":"6371_CR44","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.1158\/0008-5472.CAN-08-1740","volume":"68","author":"P Eichhorn","year":"2008","unstructured":"Eichhorn P, Gili M, Scaltriti M, Serra V, Guzman M, Nijkamp W, et al. Phosphatidylinositol 3-kinase hyperactivation results in lapatinib resistance that is reversed by the mtor\/phosphatidylinositol 3-kinase inhibitor nvp-bez235. Can Res. 2008;68(22):9221\u201330. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1740.","journal-title":"Can Res"},{"issue":"4","key":"6371_CR45","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.molcel.2021.01.033","volume":"81","author":"R Mukherjee","year":"2021","unstructured":"Mukherjee R, Vanaja KG, Boyer JA, Gadal S, Solomon H, Chandarlapaty S, et al. Regulation of pten translation by pi3k signaling maintains pathway homeostasis. Mol Cell. 2021;81(4):708\u201323. https:\/\/doi.org\/10.1016\/j.molcel.2021.01.033.","journal-title":"Mol Cell"},{"issue":"2","key":"6371_CR46","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1042\/bj3420287","volume":"342","author":"A Casamayor","year":"1999","unstructured":"Casamayor A, Morrice NA, Alessi DR. Phosphorylation of ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in vivo. Biochem J. 1999;342(2):287\u201392. https:\/\/doi.org\/10.1042\/bj3420287.","journal-title":"Biochem J"},{"issue":"12","key":"6371_CR47","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1074\/mcp.M112.019919","volume":"11","author":"K Imami","year":"2012","unstructured":"Imami K, Sugiyama N, Imamura H, Wakabayashi M, Tomita M, Taniguchi M, et al. Temporal profiling of lapatinib-suppressed phosphorylation signals in egfr\/her2 pathways. Mol Cell Proteomics. 2012;11(12):1741\u201357. https:\/\/doi.org\/10.1074\/mcp.M112.019919.","journal-title":"Mol Cell Proteomics"},{"key":"6371_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-9966-28-152","volume":"28","author":"L Xiao","year":"2009","unstructured":"Xiao L, Wang YC, Li WS, Du Y. The role of mtor and phospho-p70s6k in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray. J Exp Clin Cancer Res. 2009;28:1\u20139. https:\/\/doi.org\/10.1186\/1756-9966-28-152.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"6371_CR49","doi-asserted-by":"publisher","first-page":"550","DOI":"10.18632\/oncotarget.6375","volume":"7","author":"R Duchnowska","year":"2015","unstructured":"Duchnowska R, Wysocki PJ, Korski K, Czartoryska-Ar\u0142ukowicz B, Niwi\u0144ska A, Orlikowska M, et al. Immunohistochemical prediction of lapatinib efficacy in advanced her2-positive breast cancer patients. Oncotarget. 2015;7(1):550. https:\/\/doi.org\/10.18632\/oncotarget.6375.","journal-title":"Oncotarget"},{"issue":"11","key":"6371_CR50","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1158\/1535-7163.MCT-14-0330","volume":"13","author":"E Rozengurt","year":"2014","unstructured":"Rozengurt E, Soares HP, Sinnet-Smith J. Suppression of feedback loops mediated by pi3k\/mtor induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance. Mol Cancer Ther. 2014;13(11):2477\u201388. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0330.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"6371_CR51","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.celrep.2015.03.037","volume":"11","author":"TJ Stuhlmiller","year":"2015","unstructured":"Stuhlmiller TJ, Miller SM, Zawistowski JS, Nakamura K, Beltran AS, Duncan JS, et al. Inhibition of lapatinib-induced kinome reprogramming in erbb2-positive breast cancer by targeting bet family bromodomains. Cell Rep. 2015;11(3):390\u2013404. https:\/\/doi.org\/10.1016\/j.celrep.2015.03.037.","journal-title":"Cell Rep"},{"issue":"12","key":"6371_CR52","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1073\/pnas.1016140108","volume":"108","author":"JT Garrett","year":"2011","unstructured":"Garrett JT, Olivares MG, Rinehart C, Granja-Ingram ND, S\u00e1nchez V, Chakrabarty A, et al. Transcriptional and posttranslational up-regulation of her3 (erbb3) compensates for inhibition of the her2 tyrosine kinase. Proc Natl Acad Sci. 2011;108(12):5021\u20136. https:\/\/doi.org\/10.1073\/pnas.1016140108.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"6371_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14302\/issn.2326-0793.jpgr-13-257","volume":"1","author":"K O\u2019Connell","year":"2013","unstructured":"O\u2019Connell K, Li J, Engler F, Hennessy K, O\u2019Neill F, Straubinger RM, et al. Determination of the proteomic response to lapatinib treatment using a comprehensive and reproducible ion-current-based proteomics strategy. J Proteomics Genomics Res. 2013;1(3):27. https:\/\/doi.org\/10.14302\/issn.2326-0793.jpgr-13-257.","journal-title":"J Proteomics Genomics Res"},{"issue":"2","key":"6371_CR54","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3892\/or.2012.2159","volume":"29","author":"C Ma","year":"2013","unstructured":"Ma C, Zuo W, Wang X, Wei L, Guo Q, Song X. Lapatinib inhibits the activation of nf-$$\\kappa $$b through reducing phosphorylation of i$$\\kappa $$b-$$\\alpha $$ in breast cancer cells. Oncol Rep. 2013;29(2):812\u20138. https:\/\/doi.org\/10.3892\/or.2012.2159.","journal-title":"Oncol Rep"},{"issue":"21","key":"6371_CR55","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/bioinformatics\/btv406","volume":"31","author":"MJ Ha","year":"2015","unstructured":"Ha MJ, Baladandayuthapani V, Do K-A. Dingo: differential network analysis in genomics. Bioinformatics. 2015;31(21):3413\u201320. https:\/\/doi.org\/10.1093\/bioinformatics\/btv406.","journal-title":"Bioinformatics"},{"issue":"3","key":"6371_CR56","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/biostatistics\/kxm045","volume":"9","author":"J Friedman","year":"2008","unstructured":"Friedman J, Hastie T, Tibshirani R. Sparse inverse covariance estimation with the graphical lasso. Biostatistics. 2008;9(3):432\u201341.","journal-title":"Biostatistics"},{"issue":"D1","key":"6371_CR57","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. String v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(D1):447\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"6371_CR58","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/nar\/gku1204","volume":"43","author":"A Chatr-Aryamontri","year":"2015","unstructured":"Chatr-Aryamontri A, Breitkreutz B-J, Oughtred R, Boucher L, Heinicke S, Chen D, et al. The biogrid interaction database: 2015 update. Nucleic Acids Res. 2015;43(D1):470\u20138.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-026-06371-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-026-06371-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-026-06371-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:21:21Z","timestamp":1775035281000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12859-026-06371-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6371"],"URL":"https:\/\/doi.org\/10.1186\/s12859-026-06371-w","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no Conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}